Reviewing Nexalin Technology (NASDAQ:NXL) & GigCapital5 (NYSE:GIA)

Nexalin Technology (NASDAQ:NXLGet Free Report) and GigCapital5 (NYSE:GIAGet Free Report) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Profitability

This table compares Nexalin Technology and GigCapital5’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Nexalin Technology -4,185.46% -122.57% -97.00%
GigCapital5 N/A N/A -14.85%

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Nexalin Technology and GigCapital5, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nexalin Technology 0 0 0 0 N/A
GigCapital5 0 0 0 0 N/A

Earnings & Valuation

This table compares Nexalin Technology and GigCapital5’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Nexalin Technology $110,000.00 97.06 -$4.65 million N/A N/A
GigCapital5 N/A N/A -$2.77 million N/A N/A

GigCapital5 has lower revenue, but higher earnings than Nexalin Technology.

Institutional and Insider Ownership

0.7% of Nexalin Technology shares are owned by institutional investors. Comparatively, 27.3% of GigCapital5 shares are owned by institutional investors. 27.7% of Nexalin Technology shares are owned by company insiders. Comparatively, 75.4% of GigCapital5 shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Volatility and Risk

Nexalin Technology has a beta of 5.8, indicating that its share price is 480% more volatile than the S&P 500. Comparatively, GigCapital5 has a beta of 0.03, indicating that its share price is 97% less volatile than the S&P 500.

Summary

GigCapital5 beats Nexalin Technology on 6 of the 8 factors compared between the two stocks.

About Nexalin Technology

(Get Free Report)

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.

About GigCapital5

(Get Free Report)

GigCapital5, Inc. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Palo Alto, California.GigCapital5, Inc operates as a subsidiary of GigAcquisitions5, LLC

Receive News & Ratings for Nexalin Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexalin Technology and related companies with MarketBeat.com's FREE daily email newsletter.